The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients

@inproceedings{Charpentier2011TheDS,
  title={The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients},
  author={Guillaume Charpentier and Pierre Yves Benhamou and Dured Dardari and Annie Clergeot and Sylvia Franc and Pauline Schaepelynck-Belicar and Bogdan Catargi and Vincent Melki and Lucy Chaillous and Anne Farret and Jean-Luc Bosson and Alfred Penfornis},
  booktitle={Diabetes care},
  year={2011}
}
OBJECTIVE To demonstrate that Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support significantly improves HbA(1c) in poorly controlled type 1 diabetic patients. RESEARCH DESIGN AND METHODS In a six-month open-label parallel-group, multicenter study, adult patients (n = 180) with type 1 diabetes (>1 year), on a basal-bolus insulin regimen (>6 months), with HbA(1c) ≥ 8%, were randomized to usual quarterly follow-up (G1), home use of a smartphone… CONTINUE READING